fda removes semaglutide from drug shortage list february 2025 US judge upholds FDA's removal of Ozempic, Wegovy The FDA Is About to
Description
What are your thoughts
Kicking off the forum, Kat Cole spoke on a panel exploring the intersection of metabolic hormones, patient experience, and market innovation
Learn about Emily Oster in this episode on the exaggerated benefits of breastfeeding and the rising C-section rate.
Design Systematic review and network meta-analysis
Family physicians play a critical role in guiding patients through the complexities of injectable weight loss medication use and discontinuation.
